Publications by authors named "Marija Kalaba"

Claim this Profile
C
Clinical implications of prenatal diagnosis of aorto-left ventricular tunnel on postnatal treatment and final outcome.
Jovan Kosutic, Sergej Prijic, Mila Stajevic, Marija Kalaba, Sanja Ninic

Turk J Pediatr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries?
Marija Kalaba, Jovan Kosutic, Brian Godman, Vesela Radonjic, Ana Vujic, Zlatko Kalaba

J Comp Eff Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policies for biosimilar uptake in Europe: An overview.
Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Marija Kalaba

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P Martin, Jesper Van Den Bergh, Marija Kalaba

Front Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful use of sirolimus for refractory atrial ectopic tachycardia in a child with cardiac rhabdomyoma.
Sanja Ninic, Marija Kalaba, Bosiljka Jovicic, Vladislav Vukomanovic, Sergej Prijic

Ann Noninvasive Electrocardiol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consumption of antihistamines in Serbia in the period 2011-2015 and the correlation with adverse drug reaction reports.
Vesela Radonjić, Ivana Jović, Marija Kalaba, Brian Godman, Jovan Košutić

Vojnosanit Pregl· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.
Elisabetta Poluzzi, Emanuel Raschi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
Emanuel Raschi, Elisabetta Poluzzi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?
Brian Godman, Rickard E Malmström, Eduardo Diogene, Andy Gray, Sisira Jayathissa, Marija Kalaba

Expert Rev Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.
Brian Godman, Bjorn Wettermark, Menno van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Marija Kalaba

Front Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Brian Godman, Rickard E Malmström, Eduardo Diogene, Sisira Jayathissa, Stuart McTaggart, Marija Kalaba

Front Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing health care: feasibility and future implications.
Brian Godman, Alexander E Finlayson, Parneet K Cheema, Eva Zebedin-Brandl, Inaki Gutiérrez-Ibarluzea, Marija Kalaba

BMC Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Rickard E Malmström, Brian B Godman, Eduard Diogene, Christoph Baumgärtel, Marion Bennie, Marija Kalaba

Front Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?
Marija Kalaba, Brian Godman, Aleksandar Vuksanović, Marion Bennie, Richard E Malmström

J Comp Eff Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policies to enhance prescribing efficiency in europe: findings and future implications.
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Marija Kalaba

Front Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Marija Kalaba

Expert Rev Pharmacoecon Outcomes Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Marija Kalaba

Pharmaceuticals (Basel)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Jakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, Bogusława Osińska, Harald Herholz, Marija Kalaba

BMC Health Serv Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis